Green Mountain Extends Rally (TARO, SNY. GWR, GMCR)

Green Mountain Extends Rally (TARO, SNY. GWR, GMCR)

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) shares declined 1.54% to $40.34 in the morning hour after Sun Pharmaceutical Industries Ltd and Taro Pharmaceutical announced that they have entered into a merger agreement together with certain affiliates of Sun Pharma. The merger agreement provides that all shareholders of Taro other than Sun Pharma and its affiliates will receive a cash payment of $39.50 per share upon the closing of the merger. Sun Pharma and its affiliates collectively own approximately 66.0% of the outstanding Taro ordinary shares and 100% of Taro’s founders shares, representing approximately 77.5% of the outstanding voting power in Taro.

Sanofi SA (ADR) (NYSE:SNY) stock fell 0.05% to $41.58 after the company announced that the U.S. Food and Drug Administration (FDA) has approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Auvi-Q is the first-and-only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process. Sanofi US licensed the North American commercialization rights to Auvi-Q from Intelliject, Inc., which has retained commercialization rights for the rest of the world.

Genesee & Wyoming Inc. (NYSE:GWR) stock gained 0.05% to $64.34 after the company posted traffic volumes for July 2012. The company’s traffic in July 2012 was 80,858 carloads, a decrease of 4,341 carloads, or 5.1%, as compared with July 2011. Excluding 2,893 carloads from GWI railroads acquired within the last 12 months, same-railroad traffic in July 2012 decreased 7,234 carloads, or 8.5%, compared with July 2011.

Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) shares climbed 3.89% to $25.25 in the early hour. The 52 week trading range for the company is $17.11 – $115.98. On August 1, 2012, the company’s fiscal third-quarter income grew 30%, as the company posted stronger sales of its K-cup coffee and tea portion packs, but margins continued to contract over softer-than-anticipated demand.

Looking forward, the company forecasted fourth quarter adjusted earnings of $0.45 a share to $0.50 a share on sales growth of 25% to 30%. Analysts most recently predicted earnings of $0.62 a share on revenue growth of 34%.